"While the rescinded grant is undoubtedly a setback, it also sharpens our focus on the solid foundation already established ...

The acquisition marks a turning point for the company after months of financial uncertainty and data breach concerns.

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility ...

The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.

In the Phase 2 study of patients with chronic kidney disease, the highest dose of the drug lowered by 86% the levels of ...

Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter ...

Schrödinger is laying off 60 staffers, or about 7% of its workforce, in an effort to save cash and boost efficiency. | ...

Pacibekitug, an antibody targeting interleukin-6, hit the primary endpoint in the phase 2 Tranquility trial by sharply ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

Chinese biotech company 3SBio's shares surged early Tuesday after its around US$6 billion licensing deal with Pfizer to develop, manufacture and commercialize a promising cancer drug. Shares were up ...

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It ...

About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...